Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2727  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Parkinson's disease: A review

Radhakrishnan Divya M, Goyal Vinay

Year : 2018| Volume: 66| Issue : 7 | Page no: 26-35

   This article has been cited by
 
1 Effects of a probiotic suspension Symproveô on a rat early-stage Parkinsonís disease model
Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer
Frontiers in Aging Neuroscience. 2023; 14
[Pubmed]  [Google Scholar] [DOI]
2 Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, BŠrbara de Oliveira Zanuso, Maria Eduardo Figueira, Rosa Direito, Ricardo de Alvares Goulart, Daiene Santos Buglio, Sandra Maria Barbalho
Pharmaceutics. 2023; 15(1): 229
[Pubmed]  [Google Scholar] [DOI]
3 Role of Neddylation in Neurodegenerative Diseases
Manoj Govindarajulu, Sindhu Ramesh, Tharanth Shankar, Murali Krishna Kora, Timothy Moore, Muralikrishnan Dhanasekaran
NeuroSci. 2022; 3(4): 533
[Pubmed]  [Google Scholar] [DOI]
4 Role of SUMOylation in Neurodegenerative Diseases
Nicolas Mandel, Nitin Agarwal
Cells. 2022; 11(21): 3395
[Pubmed]  [Google Scholar] [DOI]
5 MPC-STANet: Alzheimerís Disease Recognition Method Based on Multiple Phantom Convolution and Spatial Transformation Attention Mechanism
Yujian Liu, Kun Tang, Weiwei Cai, Aibin Chen, Guoxiong Zhou, Liujun Li, Runmin Liu
Frontiers in Aging Neuroscience. 2022; 14
[Pubmed]  [Google Scholar] [DOI]
6 Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
Manisha Pandey, Neha Jain, Jovita Kanoujia, Zahid Hussain, Bapi Gorain
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
7 Ganoderic Acid A targeting leucine-rich repeat kinase 2 involved in Parkinson's diseaseĖA computational study
Faizan Ahmad
AGING MEDICINE. 2022;
[Pubmed]  [Google Scholar] [DOI]
8 Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
Zahra Dorostgou, Negar Yadegar, Zeynab Dorostgou, Fariborz Khorvash, Omid Vakili
Journal of Neuroscience Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review
Shubham Upadhayay, Rishav Gupta, Surbhi Singh, Maroti Mundkar, Gursewak Singh, Puneet Kumar
Cellular and Molecular Neurobiology. 2022;
[Pubmed]  [Google Scholar] [DOI]
10 Effects of radiation exposure on brain health: a state of the art and new challenges
Jayalakshmi Jayan, Harsha Roshi, Fathima Farzana Perumbilly Ashraf, Parvathy G. Nair, Aparna Vijayakumar, Aathira Sujathan Nair, Leena K. Pappachen, Mohamed A. Abdelgawad, Della Grace Thomas Parambi, Lotfi Aleya, Bijo Mathew
Environmental Science and Pollution Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
11 Chemically induced models of Parkinson's disease
Thilaga Thirugnanam, Kirankumar Santhakumar
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2022; 252: 109213
[Pubmed]  [Google Scholar] [DOI]
12 Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease
Muhammad Usama Ashhar, Preeti Vyas, Divya Vohora, Pravat Kumar Sahoo, Kuldeep Nigam, Shweta Dang, Javed Ali, Sanjula Baboota
International Journal of Pharmaceutics. 2022; 618: 121683
[Pubmed]  [Google Scholar] [DOI]
13 Parkinsonís disease diagnosis using neural networks: Survey and comprehensive evaluation
M. Tanveer, A.H. Rashid, Rahul Kumar, R. Balasubramanian
Information Processing & Management. 2022; 59(3): 102909
[Pubmed]  [Google Scholar] [DOI]
14 Mass spectrometry-based proteomics analysis of human substantia nigra from Parkinson's disease patients identifies multiple pathways potentially involved in the disease
Yura Jang, Olga Pletnikova, Juan C. Troncoso, Alexander Y. Pantelyat, Ted M. Dawson, Liana S. Rosenthal, Chan Hyun Na
Molecular & Cellular Proteomics. 2022; : 100452
[Pubmed]  [Google Scholar] [DOI]
15 Rotenone induces regionally distinct a-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, Debotri Chatterjee, Richard J. Smeyne, Ronald B. Tjalkens
Neurobiology of Disease. 2022; 167: 105685
[Pubmed]  [Google Scholar] [DOI]
16 Quantitative Transcranial Sonography Evaluation of Substantia Nigra Hyperechogenicity Is Useful for Predicting Levodopa-Induced Dyskinesia in Parkinson Disease
Jia-Hui Yan, Kai Li, Yi-Lun Ge, Wen Li, Pu-Zhi Wang, Hong Jin, Jin-Ru Zhang, Jing Chen, Fen Wang, Ya-Ping Yang, Ying-Chun Zhang, Dan Li, Cheng-Jie Mao, Chun-Feng Liu
Ultrasound in Medicine & Biology. 2022;
[Pubmed]  [Google Scholar] [DOI]
17 Endosomal recycling protein Rab11 in Parkin and Pink1 signaling in Drosophila model of Parkinson's disease
Pooja Rai, Jagat Kumar Roy
Experimental Cell Research. 2022; : 113357
[Pubmed]  [Google Scholar] [DOI]
18 Glycolysis: The Next Big Breakthrough in Parkinsonís Disease
Unaiza Naeem, Abdul Rehman Arshad, Areesha Jawed, Farea Eqbal, Laiba Imran, Zayeema Khan, Farhat Ijaz
Neurotoxicity Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
19 Western and ketogenic diets in neurological disorders: can you tell the difference?
Karl John Habashy, Fatima Ahmad, Stanley Ibeh, Sarah Mantash, Fatima Kobeissy, Hawraa Issa, Ralph Habis, Ali Tfaily, Sanaa Nabha, Hayat Harati, Mohammad Amine Reslan, Yara Yehya, Chloe Barsa, Abdullah Shaito, Kazem Zibara, Ahmed F El-Yazbi, Firas H Kobeissy
Nutrition Reviews. 2022;
[Pubmed]  [Google Scholar] [DOI]
20 Effects of Baduanjin exercise on motor function, balance and gait in Parkinsonís disease: a systematic review and meta-analysis
Jinghui Lai, Yangfan Cai, Liyan Yang, Min Xia, Xi Cheng, Ying Chen
BMJ Open. 2022; 12(11): e067280
[Pubmed]  [Google Scholar] [DOI]
21 Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment
Xiao-Xiao Fu, Jin Wang, Hua-Ying Cai, Hong Jiang, Jin-Zhan Jiang, Hao-Hao Chen, Shu Han
Journal of Inflammation Research. 2022; Volume 15: 3797
[Pubmed]  [Google Scholar] [DOI]
22 A Systematic Review of Machine Learning Based Gait Characteristics in Parkinsonís Disease
Pooja Sharma, SK Pahuja, Karan Veer
Mini-Reviews in Medicinal Chemistry. 2022; 22(8): 1216
[Pubmed]  [Google Scholar] [DOI]
23 Effect of Shenfu injection on the level of acetylcholine in acute liver injury of young rats with sepsis
Jian WU, Wei YU, Jianping ZHU, Yun LIU, Yanhong SHEN, Mengsi SUN, Guoqiang JIN
Minerva Gastroenterology. 2022; 68(3)
[Pubmed]  [Google Scholar] [DOI]
24 Clinical efficacy of probiotics in the treatment of constipation in Parkinson's patients
Ting YAN, Jinzi SHI, Xiang LI
Minerva Gastroenterology. 2022; 68(3)
[Pubmed]  [Google Scholar] [DOI]
25 Application of neurotoxin- and pesticide-induced animal models of Parkinsonís disease in the evaluation of new drug delivery systems
Yaquelyn Casanova, Sofia Negro, Emilia Barcia
Acta Pharmaceutica. 2022; 72(1): 35
[Pubmed]  [Google Scholar] [DOI]
26 The recent guidelines for pharmacotherapy of Parkinsonís Disease
Tomasz Karabin, Grazyna Biala, Marta Kruk-Slomka
Current Issues in Pharmacy and Medical Sciences. 2022; 0(0)
[Pubmed]  [Google Scholar] [DOI]
27 Depression and Quality of Life of Parkinsonís disease patients Ė A hospital-based cross-sectional study
Maanasa Rajagopalan, Lakshmi Narasimhan Ranganathan, S. Valarmathi, Srinivas Govindarajulu, Sudha Seshayyan
Indian Journal of Medical Sciences. 2022; 0: 1
[Pubmed]  [Google Scholar] [DOI]
28 The Positive Role and Mechanism of Herbal Medicine in Parkinsonís Disease
Rong Yin, Jie Xue, Yanfeng Tan, Chuantao Fang, Chunchun Hu, Qian Yang, Xinyu Mei, Dashi Qi, Silvana Hrelia
Oxidative Medicine and Cellular Longevity. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
29 Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinsonís disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea, Simona Bungau
Translational Neurodegeneration. 2021; 10(1)
[Pubmed]  [Google Scholar] [DOI]
30 The impact of clinical scales in Parkinsonís disease: a systematic review
Nikita Aggarwal, Barjinder Singh Saini, Savita Gupta
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021; 57(1)
[Pubmed]  [Google Scholar] [DOI]
31 Effects of domotics on cognitive, social and personal functioning in patients with Parkinsonís disease: A pilot study
Desiree Latella, Maria Grazia Maggio, Giuseppa Maresca, Adriana Andaloro, Smeralda Anchesi, Valentina Pajno, Rosaria De Luca, Giuseppe Di Lorenzo, Alfredo Manuli, Rocco Salvatore CalabrÚ
Assistive Technology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
32 Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy
Rongbo Zhang, Jing Li, You Wu, Shunli Liang, Linsheng Xu
Genetic Testing and Molecular Biomarkers. 2021; 25(1): 20
[Pubmed]  [Google Scholar] [DOI]
33 Automatic and non-invasive Parkinsonís disease diagnosis and severity rating using LSTM network
Balaji E., Brindha D., Vinodh Kumar Elumalai, Vikrama R.
Applied Soft Computing. 2021; 108: 107463
[Pubmed]  [Google Scholar] [DOI]
34 Therapeutic Regime to Ameliorate Quality of Life in Patients with Parkinsonís Disease
Nidhi Sharma, Manpreet Kaur, Anju Goyat, Priyanka Sharma, Adarsh Kumar Srivastav, B. K. Agrawal
Physical & Occupational Therapy In Geriatrics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
35 Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of a-synuclein fibrillation: Biophysical and insilico studies
Tinku, Harshad Paithankar, Ankita R. Rane, Ramakrishna V. Hosur, Sinjan Choudhary
Journal of Molecular Liquids. 2021; 334: 116105
[Pubmed]  [Google Scholar] [DOI]
36 Mutational Impact on ďin-Between-RingĒ (IBR) Domain of PARKIN on Protein Stability and Function
Sima Biswas, Angshuman Bagchi
Applied Biochemistry and Biotechnology. 2021; 193(6): 1603
[Pubmed]  [Google Scholar] [DOI]
37 Recent Progress in Non-motor Features of Parkinsonís Disease with a Focus on Circadian Rhythm Dysregulation
Yufei Liu, Long Niu, Xinyao Liu, Cheng Cheng, Weidong Le
Neuroscience Bulletin. 2021; 37(7): 1010
[Pubmed]  [Google Scholar] [DOI]
38 The Histaminergic System in Neuropsychiatric Disorders
Li Cheng, Jiaying Liu, Zhong Chen
Biomolecules. 2021; 11(9): 1345
[Pubmed]  [Google Scholar] [DOI]
39 Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinsonís Disease via Activating the JAK2/STAT3 Pathway
ZhengHu Xu, Dongfeng Yang, Xiaojing Huang, Huai Huang
Frontiers in Neuroscience. 2021; 15
[Pubmed]  [Google Scholar] [DOI]
40 Local Translation in Nervous System Pathologies
MarŪa Gamarra, Aida de la Cruz, Maite Blanco-Urrejola, Jimena Baleriola
Frontiers in Integrative Neuroscience. 2021; 15
[Pubmed]  [Google Scholar] [DOI]
41 Neuroprotective effects of oleuropein: Recent developments and contemporary research
Masood Sadiq Butt, Urwa Tariq, Iahtisham-Ul-Haq, Ambreen Naz, Muhammad Rizwan
Journal of Food Biochemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
42 Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinsonís Disease
Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, Camille Sena-dos-Santos, Tatiane Piedade de Souza, Natacha M. Souza Portís, Jhully Azevedo dos Santos Pinheiro, ¬ndrea Ribeiro-dos-Santos, Amanda F. Vidal
International Journal of Molecular Sciences. 2021; 22(18): 9839
[Pubmed]  [Google Scholar] [DOI]
43 Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo, Mariarosa Anna Beatrice Melone
Pharmaceutics. 2021; 13(11): 1897
[Pubmed]  [Google Scholar] [DOI]
44 Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
Dejan Aleksic, Srdan Stefanovic, Miloö Milosavljevic, Jovana Milosavljevic, Slobodan Jankovic
Hospital Pharmacology - International Multidisciplinary Journal. 2021; 8(3): 1099
[Pubmed]  [Google Scholar] [DOI]
45 The Correlation Between Parkinsonís Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review
Niki Shrestha, Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Lubna Mohammed
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
46 Subcutaneous apomorphine in advanced Parkinsonís disease and its use in Indian population
Vinod Metta, Rupam Borgohain, Prashanth L Kukkle, Rukmini Mridula, Pankaj Agarwal, Asha Kishore, Vinay Goyal, Ray Chaudhuri
Annals of Movement Disorders. 2020; 3(3): 145
[Pubmed]  [Google Scholar] [DOI]
47 Natural Approaches for Neurological DisordersóThe Neuroprotective Potential of Codium tomentosum
Joana Silva, Alice Martins, Celso Alves, Susete Pinteus, Helena Gaspar, Amparo Alfonso, Rui Pedrosa
Molecules. 2020; 25(22): 5478
[Pubmed]  [Google Scholar] [DOI]
48 Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinsonís Disease: A Perspective on Associated Therapeutic Interventions
Tapan Behl, Gagandeep Kaur, Simona Bungau, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gokhan Zengin, Roxana Brata, Syed Shams ul Hassan, Ovidiu Fratila
International Journal of Molecular Sciences. 2020; 21(17): 6235
[Pubmed]  [Google Scholar] [DOI]
49 Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinsonís Disease
Siyan Zhang, Kai Tao, Jia Wang, Yunyou Duan, Bao Wang, Xi Liu
Frontiers in Cellular Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
50 Curcumin and neurological diseases
Raffaella Adami, Daniele Bottai
Nutritional Neuroscience. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
51 Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinsonís disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chen-hong Guo, Ting Cao, Long-tai Zheng, John L Waddington, Xue-chu Zhen
Acta Pharmacologica Sinica. 2020; 41(4): 499
[Pubmed]  [Google Scholar] [DOI]
52 The potential role of metformin in the treatment of Parkinson's disease
Mengnan Lu, Huangtao Chen, Fayi Nie, Xinyi Wei, Zhiwei Tao, Jie Ma
Journal of Bio-X Research. 2020; 3(1): 27
[Pubmed]  [Google Scholar] [DOI]
53 Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinsonís Disease
Jagatheesh Kaliaperumal, Satguru Dulari, Pandurangan A. , Mahendra Singh Rathore, Amit Mittal, Md. Shamshir Alam
Journal of Evolution of Medical and Dental Sciences. 2020; 9(34): 2466
[Pubmed]  [Google Scholar] [DOI]
54 NŲrodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli
Cem HAZIR, Gamze BORA, Hayat Erdem YURTER
Uludag ‹niversitesi Tip FakŁltesi Dergisi. 2020;
[Pubmed]  [Google Scholar] [DOI]
55 Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinsonís Disease
Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora
Current Neuropharmacology. 2020; 19(2): 233
[Pubmed]  [Google Scholar] [DOI]
56 Orally Administered Nanotherapeutics For Parkinsonís Disease: An Old Delivery System Yet More Acceptable
Nidhi Aggarwal, Zufika Qamar, Saleha Rehman, Sanjula Baboota, Javed Ali
Current Pharmaceutical Design. 2020; 26(19): 2280
[Pubmed]  [Google Scholar] [DOI]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow